Filing Details

Accession Number:
0001104659-21-110538
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-27 16:13:06
Reporting Period:
2021-08-26
Accepted Time:
2021-08-27 16:13:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818382 Humacyte Inc. HUMA Biological Products, (No Disgnostic Substances) (2836) 851763759
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1878024 Ayabudge Llc 2525 East North Carolina Highway 54
Durham NC 27713
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-26 18,930,004 $0.00 18,930,004 No 4 A Direct
Common Stock Acquisiton 2021-08-26 1,522,500 $10.00 20,452,504 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Footnotes
  1. On August 26, 2021, Alpha Health care Acquisition Corp. ("AHAC") consummated a business combination (the "Business Combination") by and among AHAC, Hunter Merger Sub, Inc., a Delaware corporation ("Hunter Merger Sub") and Humacyte, Inc., a Delaware corporation ("Legacy Humacyte"), AHAC changed its name to "Humacyte, Inc." and Hunter Merger Sub merged with and into Legacy Humacyte. As part of the Business Combination, each share of Legacy Humacyte stock was exchanged for 0.2626 shares of common stock of Humacyte, Inc.